Results

Total Results: 39 records

Showing results for "harms".

21. Published Projects | SRDR
    srdrplus.ahrq.gov/published_projects
    February 28, 2024 - language delay or disorders enrolling children age 6 years or younger reporting on the benefits and harms … No RCTs reported on the harms of interventions. … harms of interventions. … No RCTs reported on the harms of interventions. … harms of interventions.

22. Published Projects | SRDR
    srdrplus.ahrq.gov/published_projects?page=21
    June 27, 2021 - and supplements an updated USPSTF report on screening for any drug use, focusing on the benefits and harms … months for drug use or other risky behaviors; health, social, and legal consequences of drug use; or harms … No study evaluated benefits or harms of preemptive naloxone prescribed in primary care settings versus … Evidence on harms of pharmacotherapies was limited, but indicated no increased risk of serious adverse

23. Published Projects | SRDR
    srdrplus.ahrq.gov/published_projects?page=28
    June 27, 2021 - inpatient telehealth specialty consultations, no difference in mortality but also no difference in harms … Too few studies reported information on potential harms from outpatient telehealth consultations for … Included studies were English-language trials for incident fractures and harms and controlled observational … studies for additional harms outcomes. … Observational studies used variable drug treatment and control exposures and harms definitions.

24. Published Projects | SRDR
    srdrplus.ahrq.gov/published_projects?page=23
    June 27, 2021 - Evidence on harms was limited, with no evidence suggesting increased risk for serious treatment-related … harms for any intervention. … created on June 27, 2021 Last updated on June 27, 2021 Objectives: To assess the effectiveness and harms … Interferon-containing regimens were associated with a high rate of harms. … all-oral DAA regimens are associated with very high SVR rates (95.5% to 98.9% across genotypes) and few harms

25. Published Projects | SRDR
    srdrplus.ahrq.gov/published_projects?page=24
    October 31, 2022 - accuracy of CT imaging for diagnosis and staging of acute diverticulitis and conduct a de novo review of harms … for suspected acute diverticulitis; (2) it will address effectiveness, comparative effectiveness, and harms … interventional radiology techniques for acute complicated diverticulitis; (3) it will review the benefits and harms … cancer that enrolled women without preexisting breast cancer; and RCTs and observational studies of harms

26. Published Projects | SRDR
    srdrplus.ahrq.gov/published_projects?page=14
    June 27, 2022 - The 2020 report addressed benefits and harms of opioid, nonopioid pharmacologic, and nonpharmacologic … Evidence was insufficient to evaluate access, health equity, or harms outcomes. Conclusions.

27. Published Projects | SRDR
    srdrplus.ahrq.gov/published_projects?page=12
    October 06, 2022 - Our review assesses the effectiveness and harms of pain management programs that address multiple aspects … treatment decisions for cognition, function, BPSD and other outcomes, we need to clarify the benefits and harms

28. Published Projects | SRDR
    srdrplus.ahrq.gov/published_projects?page=46
    June 23, 2021 - and radiation therapy for NMIBC that evaluated bladder cancer recurrence, progression, mortality, or harms … effectiveness reported impact on primary clinical outcomes (e.g., mortality and morbidity) or identified harms … Conclusions: The full impact of HIE on clinical outcomes and potential harms is inadequately studied,

29. Published Projects | SRDR
    srdrplus.ahrq.gov/published_projects?page=43
    June 27, 2021 - To assess the efficacy, comparative effectiveness, and harms of treatments for insomnia disorder in the … measures that assess both sleep and daytime functioning associated with sleep), sleep parameters, and harms … Administration (FDA) labels warn about cognitive and behavioral changes, including driving impairment, and other harms … Observational studies suggest an association of hypnotics with infrequent but serious, harms.

30. Published Projects | SRDR
    srdrplus.ahrq.gov/published_projects?page=30
    June 27, 2021 - osteoarthritis of the knee, hip, or hand, fibromyalgia, and tension headache) that addressed efficacy or harms … There was no evidence suggesting increased risk for serious treatment-related harms for any of the interventions … , although data on harms were limited. … Information on harms was limited across all drug and nondrug studies.

31. Published Projects | SRDR
    srdrplus.ahrq.gov/published_projects?page=51
    June 23, 2021 - Objectives: The objective of this report was to compare the benefits and harms of bupropion, citalopram … of imaging techniques for HCC on test performance, clinical decisionmaking, clinical outcomes, and harms

32. Published Projects | SRDR
    srdrplus.ahrq.gov/published_projects?page=33
    June 27, 2021 - intravenous (IV) versus IN naloxone, evidence was insufficient to determine comparative benefits and harms … patients following successful reversal of naloxone overdose might be associated with a low rate of serious harms

33. Published Projects | SRDR
    srdrplus.ahrq.gov/published_projects?page=29
    October 31, 2022 - systematic review is to update the 2012 Comparative Effectiveness Review that evaluated the benefits and harms

34. Published Projects | SRDR
    srdrplus.ahrq.gov/published_projects?page=42
    June 27, 2021 - created on June 27, 2021 Last updated on June 27, 2021 Objectives: Comparison of the benefits and harms

35. Published Projects | SRDR
    srdrplus.ahrq.gov/published_projects?page=44
    June 27, 2021 - This review describes the body of evidence evaluating TWH interventions, assesses the benefits and harms

36. Published Projects | SRDR
    srdrplus.ahrq.gov/published_projects?page=54
    March 03, 2021 - screening and treatment for cancers involve uncertainty or tradeoffs between the expected benefits and harms

37. Published Projects | SRDR
    srdrplus.ahrq.gov/published_projects?page=27
    June 27, 2021 - Evidence for the comparative harms of different antidepressants was limited to single RCTs mostly studying

38. Published Projects | SRDR
    srdrplus.ahrq.gov/published_projects?page=53
    March 03, 2021 - Conclusions: Benefits and harms vary among atypical antipsychotics for off-label usage.

39. Published Projects | SRDR
    srdrplus.ahrq.gov/published_projects?page=40
    October 31, 2022 - Recently Published Projects Search for more Projects Published on June 27, 2021 Systematic Review of Treatments for Basal Cell and Squamous Cell Carcinoma of the Skin 69 Citations • 2 Key Questions • 69 Extraction Forms Project created on June 27, 2021 Last updated on June 27, 2021 Objectives: READ MORE Published on…